Results 11 to 20 of about 193,929 (276)

Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy [PDF]

open access: bronzeNature Reviews Immunology, 2021
A paradigm shift has recently occurred in the field of cancer therapeutics. Traditional anticancer agents, such as chemotherapy, radiotherapy and small-molecule drugs targeting specific signalling pathways, have been joined by cellular immunotherapies based on T cell engineering.
Emma C. Morris   +3 more
openaire   +4 more sources

Cytokine release syndrome and tumor lysis syndrome in a multiple myeloma patient treated with palliative radiotherapy: A case report and review of the literature [PDF]

open access: goldClinical and Translational Radiation Oncology, 2022
We present the case of a 53-year-old woman treated with analgesic radiotherapy for a multiple myeloma bone lesion of the forearm. After a first fraction of 5 Gray (Gy), she presented with an acute respiratory syndrome with fever a few hours after the ...
Axel Cailleteau   +5 more
doaj   +2 more sources

An explorable model of an adverse outcome pathway of cytokine release syndrome related to the administration of immunomodulatory biotherapeutics and cellular therapies. [PDF]

open access: goldFront Immunol
Mazein A   +16 more
europepmc   +2 more sources

Cytokine Release Syndrome: A Case Report. [PDF]

open access: yesCureus
Silva IF   +4 more
europepmc   +2 more sources

Cytokine Release Syndrome Following Blinatumomab Therapy [PDF]

open access: yesCureus, 2022
New therapeutic solutions have emerged in the last few decades with the growth and expansion of the field of cancer research. Amongst these new agents, immunotherapy has been prominent, particularly regarding the treatment of hematologic malignancies.
Ojemolon, Pius E   +4 more
openaire   +2 more sources

Successful immunomodulation in kidney transplant recipients with cytokine release syndrome after coronavirus disease

open access: yesIJU Case Reports, 2022
Introduction Patients with coronavirus disease, especially solid organ transplant recipients, are more susceptible to developing cytokine release syndrome than those with other viral infections.
Daiji Takamoto   +9 more
doaj   +1 more source

Collapsing Focal Segmental Glomerulosclerosis and Acute Kidney Injury Associated With Chimeric Antigen Receptor T-Cell (CAR-T) Therapy: A Case Report

open access: yesKidney Medicine, 2021
Chimeric antigen receptor T (CAR-T) cell treatment is a rapidly emerging therapy for relapsed/refractory hematologic malignancies. Although cytokine release syndrome is a common complication, a concomitant development of biopsy-proven collapsing ...
Ratna Acharya   +3 more
doaj   +1 more source

Extracorporeal cytokine removal in chimeric antigen receptor T-cell therapy associated cytokine release syndrome in patient with acute lymphoblastic leukemia. Case report

open access: yesТерапевтический архив, 2021
Сytokine release syndrome is the common complication of CAR-T therapy. We report a case of patient with B-cell acute lymphoblastic leukemia developing сytokine release syndrome with shock and multiple organ failure and requiring cytokine removal and ...
Antonina E. Shchekina   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy